Kim K, Li J, Barazia A, Tseng A, Youn S-W, Abbadessa G, Yu Y, Schwartz B, Andrews RK, Gordeuk VR, Cho J. ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease. Haematologica 2017; 102(2):246-259; https://doi.org/10.3324/haematol.2016.151159.